Clinical Trials Browser

Advanced Breast Cancer × Capecitabine × Clear all

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Phase 2 Recruiting

Advanced Breast Cancer

NCT04304352 2023-06-28

VEX

Phase 2 Unknown

Advanced Breast Cancer

NCT05255523 2022-02-24

Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer

Phase 2 Unknown

Advanced Breast Cancer

NCT00452673 2015-03-24

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

Phase 1 Completed

52 enrolled 16 charts

Advanced Breast Cancer

NCT00717951 2008-07-25

A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer

Phase 2 Unknown

Advanced Breast Cancer